期刊文献+

三氧化二砷与紫杉醇联合诱导Hep-2细胞凋亡的体外研究 被引量:4

Study in the effect of arsenic trioxide and taxol on Hep-2 in vitro
下载PDF
导出
摘要 目的研究三氧化二砷(arsenic trioxide,As2O3)与紫杉醇联合应用对人喉鳞状细胞癌Hep-2细胞株(简称Hep-2细胞)作用的影响及机制。方法以不同浓度的As2O3与浓度为10 nmol/L紫杉醇共同作用于Hep-2细胞,利用瑞氏-吉姆萨(Wrighs-Gimesa)染色及流式细胞术,观察两者对细胞凋亡及细胞周期的影响。结果 As2O3对Hep-2细胞的凋亡率具有药物浓度依赖效应,与未用药组相比,单用10 nmol/L紫杉醇对Hep-2细胞的凋亡率无明显影响。与单用As2O3组相比较,不同浓度As2O3与10 nmol/L紫杉醇具有显著协同作用,其差异有统计学意义(P﹤0.05)。结论 As2O3与紫杉醇联合用药对Hep-2细胞具有诱导凋亡的协同作用。 OBJECTIVE To investigate the effect and related mechanisms of arsenic trioxide and Taxol on cell apoptosis of a human laryngeal squamous cell carcinoma cell line(Hep-2).METHODS Hep-2 cell was treated with arsenic trioxide at different concentrations and 10 nmol/L Taxol,respectively.The apoptosis rate and the cell cycle were evaluated with Wrigh's-Gimesa and Flow cytometry.RESULTS The effect of As2O3 on apoptosis rate was concentration dependence.Compared with untreated control group,10 nmol/L Taxol was no signiflcant effect on apoptosis rate of Hep-2 cell.Compared with single As2O3 group,combination of different concentration of As2O3 and 10nmol/L Taxol has synergistic effect.The difference was statistically significant(P0.05).CONCLUSION Combination of arsenic trioxide and Taxol can induce apoptosis of Hep-2 cell lines.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2011年第4期196-199,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 鳞状细胞 细胞凋亡 抗肿瘤药 红豆杉属 三氧化二砷 Carcinoma Squamous Cell Apoptosis Antineoplastic Agents Taxus arsenic trioxide
  • 相关文献

参考文献9

  • 1Fox E, Razzouk BI, Widemann BC, et al. Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. Blood, 2008, 111: 566-573.
  • 2Jordan MA, Toso R J, Tnrower D, et al. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA, 1993, 90: 9552-9556.
  • 3Vakaet L, van Eijkeren M, The role of chemotherapy in the management of advanced laryngeal cancer. Acta Otorhinolaryngol Belg, 1992, 46: 213- 219.
  • 4Li YM, Broome JD. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res, 1999, 59: 776-780.
  • 5Haldar S, Chintapalli J, Croce CM, Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res, 1996, 56: 1253-1255.
  • 6Losler S, Schlief S, Kneifel C, et al. Antimony-trioxide-and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cefr tines, recruitment of caspases, and loss of mitochonddal membrane potential are enhanced by modulators of the cellular glutathione redox system. Ann Hematol, 2009, 88: 1047-1058.
  • 7Chen M J, Yang PY, Ye YZ, et al. Arsenic trioxide induces apoptosis in uveal melanoma cells through the mitochondrial pathway. Am J Chin Med, 2010, 38: 1131-1142.
  • 8Kitamura K, Minami Y, Yamamoto K, et al, Involvement of CD95-independent caspase 8 activation in arsenic trioxide- induced apoptosis. Leukemia, 2000, 14: 1743-1750.
  • 9尤学芬,谢玉娟,丁润生,陆德炎,姚登福.Bax基因在紫杉醇诱导HL-60细胞凋亡过程中作用的研究[J].交通医学,2007,21(2):119-120. 被引量:1

二级参考文献3

  • 1Jurgensmeier JM,Xie ZH,Deveraux Q,et al.Bax directly induces release of cytochrome c from isolated mitochondria[J].Proc Natl Acad USA,1998,95:4997-5002.
  • 2Wall NR,Mohammad RM,AL-Katib AM.Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubul in agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh[J].Leukemia Research,1999,23 (10):881-888.
  • 3尤学芬,陆德炎,姚登福,丁润生,陆建新,吴薇.紫杉醇诱导HL-60细胞凋亡的研究[J].南通医学院学报,2001,21(4):351-352. 被引量:4

同被引文献22

  • 1周锐,龙伟,陈平.重构型天冬氨酸特异性半胱氨酸蛋白酶3表达载体诱导人肺腺癌细胞凋亡的意义[J].中华结核和呼吸杂志,2005,28(8):537-540. 被引量:4
  • 2Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008.CA Cancer J Clin,2008,58:71-96.
  • 3Wang SJ,Wong G,de Heer AM,et al.CD44 variantisoforms in head and neck squamous cell carcinomaprogression.Laryngoscope,2009,119:1518-1530.
  • 4Clark JI,Hofmeister C,Choudhury A,et al.Phase IIevaluation of paclitaxel in combination with carboplatin inadvanced head and neck carcinoma.Cancer,2001,92:2334-2340.
  • 5Rowinsky EK,Donehower RC,Jones RJ,et al.Microtubulechanges and cyto-toxicity in leukemic cell lines treated withTaxol.Cancer Res,1988,48:4093-4100.
  • 6Liang Y,Meleady P,Cleary I,et al.Selection withmelphalan or paclitaxel(Taxol)yields variants with differentpatterns of multidrug resistance,integrin expression and invitro invasiveness.Eur J Cancer,2001,37:1041-1052.
  • 7Lu KH,Lue KH,Chou MC,et al.Paclitaxel inducesapoptosis via caspase-3 activation in human osteogenicsarcoma cells(U-2 OS).J Orthop Res,2005,23:988-994.
  • 8Lagas JS,Vlaming ML,van Tellingen O,et al.Multidrugresistance protein 2 is an important determinant of paclitaxelpharmacokinetics.Clin Cancer Res,2006,12:6125-6132.
  • 9Sun N,Sun X,Chen B,et al.MRP2 and GSTP1polymorphisms and chemotherapy response in advanced non-small cell lung cancer.Cancer Chemother Pharmacol,2010,65:437-446.
  • 10Swierniak A,Kimmel M,Smieja J.Mathematical modelingas a tool for planning anticancer therapy.Eur J Pharmacol,2009,625:108-121.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部